Cas:61985-24-8 N,N-diethylimidazole-1-carboxamide manufacturer & supplier

Chemical Name:N,N-diethylimidazole-1-carboxamide

CAS.NO:61985-24-8

Synonyms:imidazole-1-carboxylic acid diethylamide;imidazol-carbonsaeure-(1)-diethylamid;1-(N,N-Diethylcarbamoyl)-imidazol;N,N’-diethyl imidazolyl carboxamide;1H-Imidazole-1-carboxamide,N,N-diethyl;N,N-Diethyl-1H-imidazole-1-carboxamide;1-(diethylcarbamoyl)imidazole

Molecular Formula:C₈H₁₃N₃O

Molecular Weight:167.20800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:38.13000

Exact Mass:167.10600

LogP:1.19300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like imidazole-1-carboxylic acid diethylamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(diethylcarbamoyl)imidazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,imidazole-1-carboxylic acid diethylamide Use and application,1-(N,N-Diethylcarbamoyl)-imidazol technical grade,usp/ep/jp grade.

Related News: We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. N,N-diethylimidazole-1-carboxamide manufacturer Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. N,N-diethylimidazole-1-carboxamide supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. N,N-diethylimidazole-1-carboxamide vendor Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. N,N-diethylimidazole-1-carboxamide factory Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.